A Novel Mutation (G2172→C) in the Factor V Gene in a Chinese Family with Hereditary Activated Protein C Resistance

Thrombosis Research

Volumn 125, Issue 6, 2010, Pages 545-548

  Cai, Huacong ^a   Hua, Baolai ^a   Fan, Liankai ^a   Wang, Qian ^a   Wang, Shujie ^a   Zhao, Yongqiang ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Activated protein C resistance; Factor V; Mutation; Venous thromboembolism

Indexed keywords

ACTIVATED PROTEIN C; ASPARTIC ACID; BLOOD CLOTTING FACTOR 5; CARDIOLIPIN ANTIBODY; GLUTAMIC ACID; WARFARIN;

ADULT; AMINO ACID SUBSTITUTION; ANAMNESIS; ARTICLE; CASE REPORT; CHINESE; COLOR ULTRASOUND FLOWMETRY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DEEP VEIN THROMBOSIS; DNA CLEAVAGE; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HISTORY; FAMILY STUDY; FEMALE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SCREENING; GENOTYPE; HUMAN; LUNG EMBOLISM; MUTATIONAL ANALYSIS; PARTIAL THROMBOPLASTIN TIME; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; VEIN THROMBOSIS; ACTIVATED PROTEIN C RESISTANCE; CHINA; FAMILY; GENETICS; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PENETRANCE; POINT MUTATION; VENOUS THROMBOEMBOLISM;

ACTIVATED PROTEIN C RESISTANCE; CHINA; DNA MUTATIONAL ANALYSIS; FACTOR V; FAMILY; HUMANS; MUTATION, MISSENSE; PENETRANCE; POINT MUTATION; VENOUS THROMBOEMBOLISM;

EID: 77952548617     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.02.009     Document Type: Article

References (23)

1. Esmon C.T. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 264 (1989) 4743-4746
2. Amer L., Kisiel W., Searles R., and Williams R.J. Impairment of the protein C anticoagulant pathway in a patient with systemic lupus erythematosus, anticardiolipin antibodies and thrombosis. Thromb Res 57 (1990) 247-258
3. Dahlbäck B., Carlsson M., and Svensson P. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 90 (1993) 1004-1008
4. Zöller B., and Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 343 (1994) 1536-1538
5. Bertina R., Koeleman B.P.C., Koster T., Rosendaal F.R., Dirven R.J., Ronde Hd., et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369 (1994) 64-67
6. Greengard J., Sun X., Xu X., Fernandez J., Griffin J., and Evatt B. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 343 (1994) 1361-1362
7. Mary C., W TA, H WR, R HS, D RW, Paul E., et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 117 (2004) 19-25
8. Folsom A.R., Cushman M., Tsai M.Y., Aleksic N., Heckbert S.R., Boland L.L., et al. A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. Blood 99 (2002) 2720-2725
9. Marchiori A., Mosena L., Prins M., and Prandoni P. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies. Haematologica 92 (2007) 1107-1114
10. Mateo J., Oliver A., Borrell M., Sala N., and Fontcuberta J. Laboratory evaluation and clinical characteristics of 2, 132 consecutive unselected patients with venous thromboembolism-results of the Spanish Multicentric Study on Thrombophilia (EMET-Study). Thromb Haemost 77 (1997) 444-451
11. Bauduer F., and Lacombe D. Factor V Leiden, prothrombin 20210A, methylenetetrahydrofolate reductase 677 T, and population genetics. Mol Genet Metab 86 (2005) 91-99
12. Bai C., Pan J., and Li X. Factor V Leiden and PTG20210A gene mutation in patients with venous thrombosis and healthy blood donors. Zhonghua Yi Xue Za Zhi 79 (1999) 900-902
13. Han X., Ren J., Hao B., Cao W., Liu X., Hou L., et al. Analysis of activated protein C resistance, factor V coagulation activity and gene polymorphisms in patients with venous thromboembolism. Zhongguo Shi Yan Xue Ye Xue Za Zhi 15 (2007) 612-616
14. Jun Z., Ping T., Lei Y., Li L., Ming S., and Jing W. Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism. Clin Lab Haematol 28 (2006) 111-116
15. Wu J., Gu J., Xu J., Wang J., Sun Z., Smirnov M., et al. Factor V Leiden mutation in one family of Chinese origin. Chin Med J (Engl) 114 (2001) 379-381
16. Williamson D., Brown K., Luddington R., Baglin C., and Baglin T. Factor V Cambridge: a new mutation (Arg306-- > Thr) associated with resistance to activated protein C. Blood 91 (1998) 1140-1144
17. Jenny R.J., Pittman D.D., JToole J., Kriz R.W., Aldape R.A., Hewick R.M., et al. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci U S A 84 (1987) 4846-4850
18. Segers K., Dahlbäck B., and Nicolaes G. Coagulation factor V and thrombophilia: background and mechanisms. Thromb Haemost 98 (2007) 530-542
19. Castoldi E., and Rosing J. Factor V Leiden: a disorder of factor V anticoagulant function. Curr Opin Hematol 11 (2004) 176-181
20. Chan W., Lee C., Kwong Y., Lam C., and Liang R. A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. Blood 91 (1998) 1135-1139
21. Castoldi E., Brugge J., Nicolaes G., Girelli D., Tans G., and Rosing J. Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations. Blood 103 (2004) 4173-4179
22. Norstrom E., Thorelli E., and Dahlbäck B. Functional characterization of recombinant FV Hong Kong and FV Cambridge. Blood 100 (2002) 524-530
23. Zhao Y., Wang X., Ding Q., Wei X., Zhu T., Kaguelidou F., et al. Antithrombin, Protein C, Protein S and Activated Protein C Resistance in the General Healthy Chinese Population: Normal Plasmatic Ranges and Genetic Defects. Blood 110 (2007) 63B Abstract